Diabetic Pathophysiology

Type2 diabetes mellitus is characterized by a both combinations of inadequate insulin secretion by pancreatic beta cells and peripheral insulin resistance. Insulin resistance, which has been associate to proinflammatory cytokines in plasma  and elevated levels of free fatty acids, it leads to decreased glucose transport into muscle cells, elevated hepatic glucose production, and increased breakdown of fat. The major role for excess glucagon cannot be underestimated; indeed, Type2 diabetes (T2D)  is an islet paracrinopathy in which the reciprocal relationship between the insulin-secreting beta cell and the glucagon-secreting alpha cell is lost, which leads to hyperglucagonemia and hence the consequent hyperglycaemia. For type 2 diabetes mellitus (T2DM) to occur, both insulin resistance and inadequate insulin secretion must exist. Generally all overweight or obese individuals have insulin resistance, but diabetes develops only in those individuals who cannot raise insulin secretion to that level so that it can compensate for their insulin resistance. Their insulin concentrations may be high, which results in low level of glycaemia.

  • Acute pancreatitis symptoms
  • Identification of β-cell dysfunction and insulin resistance
  • Differentiation of diabetes by pathophysiology, natural history
  • Clinical features of diabetes mellitus

Related Conference of Diabetic Pathophysiology

January 27-28, 2025

29th International Conference on Diabetes, Endocrinology and Healthcare

Dubai, UAE
February 24-25, 2025

34th European Diabetes Congress

London, UK
February 24-25, 2025

20th International Conference on Endocrinology and Metabolic Disorders

London, UK
March 10-11, 2025

18th European Diabetes and Endocrinology Congress

Rome, Italy
March 10-11, 2025

4th Global Summit on Physiology and Metabolism of Thyroid

Singapore City, Singapore
March 17-18, 2025

19th International Conference on Endocrinology, Diabetes and Metabolism

Singapore City, Singapore
March 17-18, 2025

5th European Endocrinology and Diabetes Congress

Paris, France
March 24-25, 2025

6th Global summit on Diabetes and Endocrinology

London, UK
April 07-08, 2025

36th International Congress on Prevention of Diabetes and Complications

Vancouver, Canada
April 10-11, 2025

31st International Conference on Human Metabolic Health- Diabetes, Obesity & Endocrinology

Dubai, UAE
April 10-11, 2025

5th World Congress on Endocrine and Diabetes

Dubai, UAE
April 10-11, 2025

27th World Congress on Diabetes and Endocrine Disorders

Dubai, UAE
April 10-11, 2025

4th International Summit on Hormonal Disorders

Dubai, UAE
April 16-17, 2025

9th International Conference on Diabetes and Cholesterol Metabolism

Tokyo, Japan
May 05-06, 2025

24th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders

Rome, Italy
May 12-13, 2025

2nd International Congress on Endocrinology and Complications of Diabetes

Rome, Italy
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland
June 24-25, 2025

23rd Global Conference on Diabetes, Endocrinology and Primary Healthcare

Paris, France
July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Aix-en-Provence, France
August 11-12, 2025

5th International Conference on Endocrinology and Diabetes

Toronto, Canada
August 28-29, 2025

34th International Diabetes and Healthcare Conference

London, UK
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
November 06-07, 2025

34th International Conference on Clinical Diabetes, Diabetic Medication & Treatment

Berlin, Germany
November 06-07, 2025

8th Annual Meeting on Diabetes and Endocrinology

Dubai, UAE
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Aix-en-Provence, France

Diabetic Pathophysiology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in